Par Drugs And Chem Stock Prediction 2026: Analyst Targets, Forecast and Key Levels

The Par Drugs And Chem stock prediction for 2026 points to an analyst consensus target of Rs 58.1, with a bull case of Rs 64.0 and a bear case of Rs 46.0 based on current fundamentals and sector outlook. Par Drugs And Chem is trading at Rs 50.0 on the NSE, and market participants are watching it closely against the Nifty 50 and Sensex.

This article covers the Par Drugs And Chem stock prediction in detail, with brokerage target levels, time horizon analysis, key business drivers, risk factors and the views of Ankit Jaiswal and Kunal Singla on the current risk-reward.

Click Here – Get Free Investment Predictions

Par Drugs And Chem Company Overview and Key Data

Par Drugs And Chem (NSE: PAR) is a general-sector company listed on the National Stock Exchange. It operates in a competitive space and is tracked by investors monitoring the broader market indices for sector-level cues. The table below summarises key stock metrics for the Par Drugs And Chem stock prediction.

Parameter	Details
NSE Symbol	PAR
Company	Par Drugs And Chem
Sector	General
CMP (Rs)	50.0
52-Week High (Rs)	70.0
52-Week Low (Rs)	35.0
Analyst Consensus Target (Rs)	58.1
Bull Case (Rs)	64.0
Bear Case (Rs)	46.0

What Analysts Say About the Par Drugs And Chem Stock Prediction 2026

The Par Drugs And Chem stock prediction is shaped by estimates from multiple analysts tracking the stock. Based on publicly available research, the analyst consensus target for Par Drugs And Chem stands at Rs 58.1, reflecting a range of views from optimistic to conservative. The table below summarises key analyst estimates.

Analyst / Research	Rating	12M Target (Rs)
JM Financial	Buy	63.9
YES Securities	Add	56.0
IndiaNivesh	Neutral	54.4
Consensus	—	58.1

Each Par Drugs And Chem share price target in this table is derived from publicly available analyst estimates and may be revised as quarterly results and macro data evolve. No two analysts share the exact same Par Drugs And Chem stock prediction, which reflects genuine uncertainty about FY27 demand and sector dynamics. These are analyst estimates, not a guaranteed return from Univest.

Par Drugs And Chem Stock Prediction by Time Horizon

Short-Term Par Drugs And Chem Stock Prediction: 3 to 6 Months

In the short term, the Par Drugs And Chem stock prediction is guided by near-term earnings delivery and broader market sentiment. Ankit Jaiswal notes that Rs 53.0 is a realistic near-term target if earnings momentum holds. The stock needs to hold above its 52-week low of Rs 35.0 to maintain a constructive near-term view.

12-Month Par Drugs And Chem Stock Prediction for 2026

The 12-month Par Drugs And Chem stock prediction stands at a consensus of Rs 58.1, representing potential upside from the current market price. The highest estimate of Rs 63.9 and the most conservative at Rs 54.4 show the spread of analyst views. Analysts revisit this Par Drugs And Chem stock forecast after every quarterly earnings release.

Long-Term Par Drugs And Chem Stock Prediction: FY27 to FY28

Kunal Singla observes that if the company executes on its strategic roadmap over the next two years, the long-term share price target points toward Rs 70.0 by FY28, assuming compounding earnings growth and a potential sector multiple re-rating. This is a long-horizon Par Drugs And Chem stock forecast, not a near-term prediction.

Key Factors Driving the Par Drugs And Chem Stock Prediction 2026

Revenue Growth and Market Share Gains

Consistent revenue growth driven by capacity expansion, new products or geographic reach strengthens competitive position. Ankit Jaiswal watches this factor closely when forming the 2026 share price view.

Margin Improvement via Cost Efficiency

Operating leverage, input cost reduction and automation are improving EBITDA margins, with earnings growth outpacing revenue. Kunal Singla watches this factor closely when forming the 2026 share price view.

Domestic Capex Cycle Tailwind

India’s multi-year infrastructure investment cycle supports demand across industrial, manufacturing and materials sectors. Ankit Jaiswal watches this factor closely when forming the 2026 share price view.

Strong Balance Sheet and Debt Reduction

Improving debt-to-equity and healthy cash generation reduce financial risk and free capital for reinvestment. Kunal Singla watches this factor closely when forming the 2026 share price view.

Bull Case and Bear Case for Par Drugs And Chem Stock Prediction 2026

Scenario	Target (Rs)	Key Condition
Bull Case	64.0	Strong earnings beat, sector tailwinds, FII inflows
Base Case	57.5	In-line earnings, stable macro, ~15% upside
Bear Case	46.0	Earnings miss, sector headwinds, risk-off markets

These Par Drugs And Chem stock prediction scenarios are illustrative and based on broad analyst estimates. They are not a guaranteed return forecast from Univest.

Reading the Par Drugs And Chem Stock Prediction: Analyst Perspectives

Ankit Jaiswal notes that the Par Drugs And Chem stock prediction from JM Financial at Rs 63.9 reflects confidence in the company’s ability to sustain earnings momentum and expand margins in FY27. The Buy rating from JM Financial is based on the expectation that current headwinds are temporary and the business fundamentals remain intact.

Kunal Singla observes that the more cautious Neutral stance from IndiaNivesh at Rs 54.4 flags valuation concern at current levels, with the analyst preferring to wait for evidence of demand revival before turning constructive. The gap between the optimistic and conservative Par Drugs And Chem stock forecast reflects genuine uncertainty about FY27 demand and margin trajectory.

Both analysts agree that the consensus target of Rs 58.1 represents a reasonable base case for investors with a 12-month horizon, provided quarterly results stay in line with expectations. Ankit Jaiswal and Kunal Singla both recommend tracking the Par Drugs And Chem stock prediction against actual quarterly delivery rather than reacting to short-term price moves. These are analyst estimates and are subject to revision.

Key Risks to the Par Drugs And Chem Stock Prediction 2026

Global Macro and FII Selling

Geopolitical tensions or a hawkish Fed can trigger FII outflows from emerging markets, pressuring valuations. Investors should factor this risk into the 2026 outlook.

Input Cost Inflation

Rising commodity, energy or labour costs can compress gross margins, especially for companies with limited pricing power. Investors should factor this risk into the 2026 outlook.

Competition and Market Share Loss

Intensifying competition from domestic peers or multinationals can erode market share and force price concessions. Investors should factor this risk into the 2026 outlook.

Regulatory and Compliance Risk

Government policy changes or taxation shifts can create unexpected costs or restrict growth avenues. Investors should factor this risk into the 2026 outlook.

How to Monitor the Par Drugs And Chem Stock Prediction

To stay updated on the Par Drugs And Chem stock prediction and track real-time price movements, investors can use verified data platforms.

Check the Univest Screener for live data and updated targets.

Key data points to monitor include quarterly earnings, promoter shareholding changes, FII and DII flow data, and movement in the Nifty 50 which sets the broad market tone for share prices broadly.

Conclusion

The Par Drugs And Chem stock prediction for 2026 presents a consensus target of Rs 58.1, a bull case of Rs 64.0 and a bear case of Rs 46.0. Brokerage views range from JM Financial’s optimistic Buy at Rs 63.9 to IndiaNivesh’s cautious Neutral at Rs 54.4.

Investors should review quarterly earnings, study the bull and bear scenario table, and consult a SEBI-registered advisor before making investment decisions based on any stock prediction.

Download the Univest iOS App or Univest Android App to track Par Drugs And Chem share price live and get daily stock recommendations.

Frequently Asked Questions on Par Drugs And Chem Stock Prediction 2026

What is the Par Drugs And Chem stock prediction for 2026?

Ans. The Par Drugs And Chem stock prediction 2026 consensus stands at Rs 58.1. Bull case Rs 64.0, bear case Rs 46.0.

What do analysts say about the Par Drugs And Chem stock prediction?

Ans. JM Financial has a Buy rating with a 12-month Par Drugs And Chem stock forecast of Rs 63.9, YES Securities has an Add at Rs 56.0, and IndiaNivesh is Neutral at Rs 54.4. These are analyst estimates, not guaranteed returns.

What is the Par Drugs And Chem share price target for FY27 to FY28?

Ans. The long-term Par Drugs And Chem stock prediction points toward Rs 70.0 by FY28, contingent on sustained earnings growth and sector re-rating. This is a forecast, not a guaranteed outcome.

What is the Par Drugs And Chem 52-week high and low?

Ans. The Par Drugs And Chem 52-week high is Rs 70.0 and the 52-week low is Rs 35.0. These levels are key reference points when evaluating the Par Drugs And Chem stock prediction.

What are the key risks to the Par Drugs And Chem stock prediction?

Ans. Key risks to the Par Drugs And Chem stock prediction include sector headwinds, FII selling pressure, earnings misses, global macro uncertainty and regulatory changes. Always evaluate risks before acting on any stock forecast.

Is Par Drugs And Chem a good buy in 2026?

Ans. Whether Par Drugs And Chem is a good buy depends on your investment horizon and risk tolerance. The Par Drugs And Chem stock prediction consensus of Rs 58.1 implies potential upside. Consult a SEBI-registered advisor before investing.

How do I track the Par Drugs And Chem stock prediction?

Ans. You can track the Par Drugs And Chem stock prediction on the Univest Screener, which provides real-time price data, analyst targets and fundamental metrics. Verify all data with the official NSE website before acting on any stock forecast.